Literature DB >> 31792898

How Safe Are Safety-Net Hospitals? Opportunities to Improve Outcomes for Vulnerable Patients Undergoing Hepatopancreaticobiliary Surgery.

Ayesha Farooq1, Anghela Z Paredes1, Katiuscha Merath1, J Madison Hyer1, Rittal Mehta1, Kota Sahara1, Diamantis I Tsilimigras1, Amika Moro1, Lu Wu1, Jordan Cloyd1, Aslam Ejaz1, Timothy M Pawlik2,3.   

Abstract

INTRODUCTION: Safety-net hospitals are critical to the US health system as they provide care to vulnerable patients. The effect of hospital safety-net burden on patient outcomes in hepatopancreaticobiliary (HPB) surgery was examined.
METHODS: Discharge data between 2004 and 2014 from the National Inpatient Sample were utilized. Hospitals with a safety-net burden were divided into tertiles: low (LBH) (< 13.6%), medium (MBH) (13.6-33.3%), and high (HBH) (> 33.3%). The association of hospital safety-net burden with complications, in-hospital mortality, never events, and costs were defined.
RESULTS: Nearly 5% of the analytic cohort (n = 65,032) had surgery at a HBH. Patients treated at HBH were younger (median age, HBH 55 years vs LBH 62 years; p < 0.001), black or Hispanic (HBH 40.5% vs LBH 12.7%; p < 0.001), and of lowest income quartile (HBH 38.4% vs LBH 19.6%; p < 0.001). One-third of patients at HBH experienced a complication compared with only a quarter of patients at LBH (p < 0.001). HBH had higher rates of in-hospital mortality (HBH 6.5% vs. LBH 2.8%; p < 0.001), never events (HBH 5.4% vs. LBH 1.4%; p < 0.001), and a higher cost of surgery (HBH $30,716 vs. LBH $28,054; p < 0.001).
CONCLUSION: Perioperative outcomes were worse at HBH, highlighting that efforts are needed to improve their delivery of care.

Entities:  

Keywords:  Disparities; HPB; Safety-net

Mesh:

Year:  2019        PMID: 31792898     DOI: 10.1007/s11605-019-04428-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  4 in total

1.  Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma.

Authors:  Shang-Chin Huang; Sih-Han Liao; Tung-Hung Su; Yung-Ming Jeng; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2021-02-05       Impact factor: 6.047

2.  Dedicated Cancer Centers are More Likely to Achieve a Textbook Outcome Following Hepatopancreatic Surgery.

Authors:  Rittal Mehta; Diamantis I Tsilimigras; Anghela Z Paredes; Kota Sahara; Mary Dillhoff; Jordan M Cloyd; Aslam Ejaz; Susan White; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2020-02-27       Impact factor: 5.344

3.  Artificial Intelligence in Cancer Staging: Limitless Potential or Passing Fad?

Authors:  John W Kunstman
Journal:  Ann Surg Oncol       Date:  2020-01-03       Impact factor: 5.344

4.  Disparities in Access to Oncologic Care in Pancreatic Cancer: A Systematic Review.

Authors:  Annabelle L Fonseca; Hamza Khan; Krista R Mehari; Deepa Cherla; Martin J Heslin; Fabian M Johnston
Journal:  Ann Surg Oncol       Date:  2022-01-23       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.